Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588K Sell
23,263
-56
-0.2% -$1.32K ﹤0.01% 1740
2026
Q1
$510K Buy
23,319
+2,673
+13% +$62K ﹤0.01% 1684
2025
Q4
$480K Sell
20,646
-1,393
-6% -$33.6K ﹤0.01% 1631
2025
Q3
$624K Buy
22,039
+7,803
+55% +$207K ﹤0.01% 1325
2025
Q2
$312K Buy
14,236
+1,099
+8% +$24K ﹤0.01% 1600
2025
Q1
$308K Buy
13,137
+295
+2% +$7.54K ﹤0.01% 1398
2024
Q4
$360K Buy
+12,842
New +$384K ﹤0.01% 1237

Other funds holding GNTX

&Partners's GNTX Position: Q2 2026 in Review

&Partners reduced its Gentex (GNTX) stake by 0.24% in Q2 2026, selling an estimated $1.32K and leaving 23,263 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

&Partners first reported a position in GNTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $624K in Q3 2025. 531 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • &Partners held 23,263 shares of Gentex worth $588K as of Q2 2026.
  • &Partners sold 56 Gentex shares in Q2 2026, an estimated $1.32K.
  • Gentex made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1740 holding.
  • &Partners first reported a position in Gentex in Q4 2024 and has held it in 7 quarters since.
  • &Partners's Gentex position peaked at $624K in Q3 2025.
  • 531 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.